In a regulatory filing, REV Group disclosed that is CFO Mark Skonieczny bought 15K shares of common stock on January 13th in a total transaction size of $136.4K, boosting his stake by about 9%.

Halozyme Therapeutics (HALO) announced that Janssen Biotech, Inc. (JNJ) has received U.S. Food and Drug Administration approval of DARZALEX FASPRO in combination with bortezomib, cyclophosphamide and dexamethasone for the treatment of adult patients with newly diagnosed light chain amyloidosis. DARZALEX FASPRO is the first and only FDA-approved treatment for patients with this rare and serious blood disorder associated with the production of an abnormal protein which leads to the deterioration of vital organs, most notably the heart, kidneys and liver.1 This indication is approved under accelerated approval and is based on the combination's hematologic complete response rate measure. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. DARZALEX FASPRO is not indicated and is not recommended for the treatment of patients with light chain amyloidosis who have NYHA Class IIIB or Class IV cardiac disease or Mayo Stage IIIB outside of controlled clinical trials.

Hilltop Holdings (HTH) will replace YETI Holdings (YETI) in the S&P SmallCap 600 as Yeti is replacing Trimble (TRMB) in the S&P MidCap 400.

YETI Holdings (YETI) will replace Trimble (TRMB) in the S&P MidCap 400 as Trimble is replacing Concho Resources (CXO) in the S&P 500.

Berkshire Hathaway disclosed a 24.9% stake in E.W. Scripps , which represents over 23M shares. The filing does not allow for activism.

NTN Buzztime announced it received a letter from the NYSE Regulation stating that it is not in compliance with NYSE American LLC continued listing standards. Specifically, the company is not in compliance with Section 704 of the NYSE American Company Guide because it did not hold an annual meeting during the fiscal year ended December 31, 2020.

In a regulatory filing, iRobot disclosed that its CEO Colin Angle sold 11.4K shares of common stock on January 13th in a total transaction size of $1.0M, reducing his stake by about 3%.

In a regulatory filing, Cloudera disclosed that its CEO Robert Bearden sold 141.8K shares of common stock on January 14th in a total transaction size of $2.03M, reducing his stake by about 18%.

Huntington Ingalls was awarded a $174.91M cost-plus-fixed-fee, indefinite-delivery/indefinite-quantity contract to provide Navy aircraft carrier Elevator Support Unit maintenance and repair. Work will be performed aboard Navy CVNs within the continental U.S.; outside the continental U.S.; and forward deployed locations according to individual task orders, and is expected to be completed by January 2026. No funds will be obligated at the time of award. Funding will be obligated on individual orders as they are issued. This contract was competitively procured and solicited via the beta.SAM.gov website. The Naval Sea Systems Command is the contracting activity.

Lockheed Martin was awarded a sole-source, cost-plus-incentive-fee, cost-plus-fixed-fee, firm-fixed-price definite contract under a Foreign Military Sales, or FMS, case to the United Arab Emirates, or UAE. The total value of this contract is $254.71M. Under this follow-on contract, the contractor will provide maintenance and sustainment for two Terminal High Altitude Area Defense batteries for UAE. The maintenance and sustainment scope of work includes providing logistics management, logistics product database, training, missile and ground repair and return, hardware/software development and sustainment, hardware in the loop, engineering services, missile field surveillance program and country unique specialty engineering for FMS client. The performance period is from January 15 through January 14, 2026. One offer was solicited and one offer was received. UAE FMS funds in the amount of $254,708,912 will be used to fund this effort. The Missile Defense Agency is the contracting activity.

In a regulatory filing, Dycom disclosed that its COO Timothy Estes sold 52K shares of common stock on January 13th in a total transaction size of $4.47M, reducing his stake by about 33%.